"Designing Growth Strategies is in our DNA"

Hyperphosphatemia Treatment Market Size, Share & Growth Analysis, By Drug Class (Sevelamer, Calcium-based Phosphate Binders, Lanthanum Carbonate, Iron-based Phosphate Binders, Others, and Non-Phosphate Binders), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2023-2030

Last Updated: March 03, 2025 | Format: PDF | Report ID: FBI100325

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Hyperphosphatemia, By Key Countries/ Regions, 2022
    2. Pipeline Analysis, By Key Players
    3. Global Revenues Generated by Major Branded Drugs
    4. New Drug Class Launches, By Key Players
    5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    6. Impact of COVID-19 on the Market
  5. Global Hyperphosphatemia Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Sevelamer
      2. Calcium-based Phosphate Binders
      3. Lanthanum Carbonate
      4. Iron-based Phosphate Binders
      5. Others
      6. Non-Phosphate Binders
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East Africa
  6. North America Hyperphosphatemia Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Sevelamer
      2. Calcium-based Phosphate Binders
      3. Lanthanum Carbonate
      4. Iron-based Phosphate Binders
      5. Others
      6. Non-Phosphate Binders
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Hyperphosphatemia Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Sevelamer
      2. Calcium-based Phosphate Binders
      3. Lanthanum Carbonate
      4. Iron-based Phosphate Binders
      5. Others
      6. Non-Phosphate Binders
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandanavia
      7. Rest of Europe
  8. Asia Pacific Hyperphosphatemia Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Sevelamer
      2. Calcium-based Phosphate Binders
      3. Lanthanum Carbonate
      4. Iron-based Phosphate Binders
      5. Others
      6. Non-Phosphate Binders
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. Australia
      4. India
      5. South East Asia
      6. Rest of Asia Pacific
  9. Latin Smerica Hyperphosphatemia Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Sevelamer
      2. Calcium-based Phosphate Binders
      3. Lanthanum Carbonate
      4. Iron-based Phosphate Binders
      5. Others
      6. Non-Phosphate Binders
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Hyperphosphatemia Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Sevelamer
      2. Calcium-based Phosphate Binders
      3. Lanthanum Carbonate
      4. Iron-based Phosphate Binders
      5. Others
      6. Non-Phosphate Binders
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. South Africa
      2. GCC
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2022)
    2. Company Profiles
      1. Sanofi
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Takeda Pharmaceutical Company Limited
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Lupin
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Astellas Pharma Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Akebia Therapeutics, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. CSL
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Ardelyx
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Unicycive
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 01: Global Hyperphosphatemia Treatment Market Revenue Breakdown (USD billion,%) by Region, 2022 & 2030

Figure 02: Global Hyperphosphatemia Treatment Market Value Share (%), by Drug Class, 2022 & 2030

Figure 03: Global Hyperphosphatemia Treatment Market Value Share (%), by Distribution Channel, 2022 & 2030

Figure 04: Global Hyperphosphatemia Treatment Market Value (USD billion), by Region, 2022 & 2030

Figure 05: North America Hyperphosphatemia Treatment Market Value (USD billion), by Drug Class, 2022 & 2030

Figure 06: North America Hyperphosphatemia Treatment Market Value Share (%), by Drug Class, 2022

Figure 07: North America Hyperphosphatemia Treatment Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 08: North America Hyperphosphatemia Treatment Market Value Share (%), by Distribution Channel, 2022

Figure 09: North America Hyperphosphatemia Treatment Market Value (USD billion), by Country/Sub-region, 2022 & 2030

Figure 10: North America Hyperphosphatemia Treatment Market Value Share (%), by Country/Sub-region, 2022

Figure 11: Europe Hyperphosphatemia Treatment Market Value (USD billion), by Drug Class, 2022 & 2030

Figure 12: Europe Hyperphosphatemia Treatment Market Value Share (%), by Drug Class, 2022

Figure 13: Europe Hyperphosphatemia Treatment Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 14: Europe Hyperphosphatemia Treatment Market Value Share (%), by Distribution Channel, 2022

Figure 15: Europe Hyperphosphatemia Treatment Market Value (USD billion), by Country/Sub-region, 2022 & 2030

Figure 16: Europe Hyperphosphatemia Treatment Market Value Share (%), by Country/Sub-region, 2022

Figure 17: Asia Pacific Hyperphosphatemia Treatment Market Value (USD billion), by Drug Class, 2022 & 2030

Figure 18: Asia Pacific Hyperphosphatemia Treatment Market Value Share (%), by Drug Class, 2022

Figure 19: Asia Pacific Hyperphosphatemia Treatment Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 20: Asia Pacific Hyperphosphatemia Treatment Market Value Share (%), by Distribution Channel, 2022

Figure 21: Asia Pacific Hyperphosphatemia Treatment Market Value (USD billion), by Country/Sub-region, 2022 & 2030

Figure 22: Asia Pacific Hyperphosphatemia Treatment Market Value Share (%), by Country/Sub-region, 2022

Figure 23: Latin America Hyperphosphatemia Treatment Market Value (USD billion), by Drug Class, 2022 & 2030

Figure 24: Latin America Hyperphosphatemia Treatment Market Value Share (%), by Drug Class, 2022

Figure 25: Latin America Hyperphosphatemia Treatment Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 26: Latin America Hyperphosphatemia Treatment Market Value Share (%), by Distribution Channel, 2022

Figure 27: Latin America Hyperphosphatemia Treatment Market Value (USD billion), by Country/Sub-region, 2022 & 2030

Figure 28: Latin America Hyperphosphatemia Treatment Market Value Share (%), by Country/Sub-region, 2022

Figure 29: Middle East and Africa Hyperphosphatemia Treatment Market Value (USD billion), by Drug Class, 2022 & 2030

Figure 30: Middle East and Africa Hyperphosphatemia Treatment Market Value Share (%), by Drug Class, 2022

Figure 31: Middle East and Africa Hyperphosphatemia Treatment Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 32: Middle East and Africa Hyperphosphatemia Treatment Market Value Share (%), by Distribution Channel, 2022

Figure 33: Middle East and Africa Hyperphosphatemia Treatment Market Value (USD billion), by Country/Sub-region, 2022 & 2030

Figure 34: Middle East and Africa Hyperphosphatemia Treatment Market Value Share (%), by Country/Sub-region, 2022

Figure 35: Global Hyperphosphatemia Treatment Market Share Analysis (%), By Company, 2022

Table 01: Global Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 02: Global Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 03: Global Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Region, 2019-2030

Table 04: North America Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 05: North America Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 06: North America Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Country / Sub-region, 2019-2030

Table 07: Europe Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 08: Europe Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 09: Europe Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2030

Table 10: Asia Pacific Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 11: Asia Pacific Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 12: Asia Pacific Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2030

Table 13: Latin America Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 14: Latin America Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 15: Latin America Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2030

Table 16: Middle East and Africa Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 17: Middle East and Africa Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 18: Middle East and Africa Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2030

Hyperphosphatemia Therapeutics Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 122
Consulting Services
    How will you benefit from our consulting services ?